Disclosed are novel compounds—benzenesulfonamides of general formulas (I) and
The compounds can be used in biomedicine as active ingredients in pharmaceutical formulations, because they inhibit enzymes which participate in disease progression. Also disclosed are method of treatment using such compounds.